VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-2.98%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$251M
AUM Growth
-$19M
(-7%)
Cap. Flow
-$3.64M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41
Top Buys
| 1 |
The Mosaic Company
MOS
|
$900K |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$877K |
| 3 |
Enphase Energy
ENPH
|
$858K |
| 4 |
Gartner
IT
|
$732K |
| 5 |
Devon Energy
DVN
|
$727K |
Top Sells
| 1 |
L3Harris
LHX
|
$740K |
| 2 |
Cheniere Energy
CQP
|
$732K |
| 3 |
Agilent Technologies
A
|
$713K |
| 4 |
Copart
CPRT
|
$688K |
| 5 |
Equifax
EFX
|
$678K |
Sector Composition
| 1 | Healthcare | 18.83% |
| 2 | Real Estate | 17.55% |
| 3 | Materials | 12.77% |
| 4 | Financials | 9.88% |
| 5 | Energy | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Prospect Capital
PSEC
$1.34B
| $359K | 0.14% |
57,940
-21,720
| -27% | -$135K |
|
252
Golub Capital BDC
GBDC
$3.93B
| $357K | 0.14% |
28,792
-8,539
| -23% | -$106K |
|
253
Hercules Capital
HTGC
$3.49B
| $354K | 0.14% |
30,591
-11,427
| -27% | -$132K |
|
254
Nuveen Floating Rate Income Fund
JFR
$1.13B
| $354K | 0.14% |
43,678
-11,997
| -22% | -$97.2K |
|
255
Alnylam Pharmaceuticals
ALNY
$59.2B
| $352K | 0.14% |
1,761
+23
| +1% | +$4.6K |
|
256
WhiteHorse Finance
WHF
$204M
| $351K | 0.14% |
31,629
-16,585
| -34% | -$184K |
|
257
Ares Capital
ARCC
$15.8B
| $347K | 0.14% |
20,578
-9,764
| -32% | -$165K |
|
|
BPMC
258
DELISTED
Blueprint Medicines
BPMC
| $340K | 0.14% |
5,165
+76
| +1% | +$5K |
|
259
BlackRock Floating Rate Income Trust
BGT
$317M
| $338K | 0.13% |
31,139
-9,087
| -23% | -$98.6K |
|
260
Saratoga Investment
SAR
$395M
| $337K | 0.13% |
16,210
-1,058
| -6% | -$22K |
|
261
Zai Lab
ZLAB
$3.42B
| $336K | 0.13% |
9,812
+143
| +1% | +$4.9K |
|
|
BSL
262
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$186M
| $335K | 0.13% |
26,682
-6,988
| -21% | -$87.7K |
|
|
EFR
263
Eaton Vance Senior Floating-Rate Fund
EFR
$343M
| $335K | 0.13% |
30,148
-6,657
| -18% | -$74K |
|
264
Crescent Capital BDC
CCAP
$591M
| $334K | 0.13% |
22,218
-3,834
| -15% | -$57.6K |
|
265
Gladstone Capital
GLAD
$582M
| $328K | 0.13% |
19,312
-1,055
| -5% | -$17.9K |
|
|
EVF
266
Eaton Vance Senior Income Trust
EVF
$101M
| $327K | 0.13% |
61,965
-15,131
| -20% | -$79.8K |
|
267
Biogen
BIIB
$20.6B
| $324K | 0.13% |
1,215
+20
| +2% | +$5.33K |
|
|
EFT
268
Eaton Vance Floating-Rate Income Trust
EFT
$319M
| $324K | 0.13% |
28,563
-7,535
| -21% | -$85.5K |
|
269
BlackRock Floating Rate Income Strategies Fund
FRA
$471M
| $322K | 0.13% |
29,242
-9,805
| -25% | -$108K |
|
270
BioCryst Pharmaceuticals
BCRX
$1.74B
| $314K | 0.13% |
24,920
+364
| +1% | +$4.59K |
|
271
Ionis Pharmaceuticals
IONS
$9.76B
| $311K | 0.12% |
7,029
+104
| +2% | +$4.6K |
|
272
Amicus Therapeutics
FOLD
$2.46B
| $310K | 0.12% |
29,698
+435
| +1% | +$4.54K |
|
273
Barings BDC
BBDC
$987M
| $308K | 0.12% |
37,228
-4,546
| -11% | -$37.6K |
|
274
Enanta Pharmaceuticals
ENTA
$189M
| $305K | 0.12% |
5,883
+85
| +1% | +$4.41K |
|
275
Oaktree Specialty Lending
OCSL
$1.23B
| $305K | 0.12% |
16,948
-3,865
| -19% | -$69.6K |
|